Clinical Trial Update: Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial of dutogliptin added to metformin in type 2 diabetes patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dutogliptin (dutogliptin)
• metformin (metformin)

Snippet

Sponsor: Phenomix | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED